Showing results (11-20 of 510) with videos related to
Sort By:
Pageof 51
Science (New York, N.Y.)|April 26, 1985
Two types of somatostatin receptors differentiated by cyclic somatostatin analogsV T Tran, M F Beal, J B MartinNeurologic Clinics|November 1, 1986
Neuropeptides in Alzheimer's disease. Clinical implicationsM F Mazurek, M F Beal, J B MartinBrain Research|November 14, 1983
Regional somatostatin distribution in the rat striatumM F Beal, V B Domesick, J B MartinBrain Research|August 11, 1987
Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's diseaseD W Ellison, M F Beal, J B MartinBrain Research|November 12, 1986
Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changesM F Beal, M F Mazurek, J B MartinNeuroscience Letters|January 21, 1985
Effects of neuroleptic drugs on brain beta-endorphin immunoreactivityM F Beal, J Fisher, D B Carr, et al.Neuroscience Letters|May 23, 1985
Immunoreactive somatostatin-28(1-12) is increased in Huntington's diseaseM F Beal, R Benoit, E D Bird, et al.Brain Research|May 12, 1987
The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleusY Tatsuoka, P N Riskind, M F Beal, et al.Neuroscience Letters|October 30, 1986
The effect of neuropeptide Y on striatal catecholaminesM F Beal, R C Frank, D W Ellison, et al.Journal of the Neurological Sciences|November 1, 1985
Human cerebrospinal fluid somatostatin in neurologic diseaseM F Beal, M F Mazurek, P M Black, et al.Pageof 51